(Q37015976)

17 August 2017

1 reference

title

Candida endophthalmitis: focus on current and future antifungal treatment options (English)

1 reference

17 August 2017

Fida A Khan

1

1 reference

17 August 2017

Douglas Slain

series ordinal

2

1 reference

17 August 2017

Rashida A Khakoo

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

27

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

1711-1721

1 reference

Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Current management of endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Experimental Hematogenous Endophthalmitis Due to Candida: Species Variation in Ocular Pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Relation between stage of endogenous fungal endophthalmitis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Use of fluconazole in the treatment of candidal endophthalmitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Pharmacotherapy of fungal eye infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Fluconazole in the management of fungal ocular infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Failure of therapy with fluconazole for candidal endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Endogenous Candida oculomycosis. Report of two patients treated with flucytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Lipid-based amphotericin B for the treatment of fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Endogenous candida endophthalmitis in a drug dependent patient: intravenous therapy with liposome encapsulated amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Use of voriconazole in candida retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Management of endogenous fungal endophthalmitis with voriconazole and caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

The safety of voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Candida glabrata endophthalmitis treated successfully with caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Current treatment strategies for disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Anidulafungin: a new echinocandin with a novel profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

Candida albicansEndophthalmitis in Brown Heroin Addicts: Response to Early Vitrectomy Preceded and Followed by Antifungal Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.12.1711

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.12.1711

1 reference

17 August 2017

1 reference